Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.

Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.

[1]  J. C. Lee,et al.  The prospects for developing a vaccine against Staphylococcus aureus. , 1996, Trends in microbiology.

[2]  R. Beavis,et al.  Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Novick,et al.  Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3'-end deletion. , 1995, FEMS microbiology letters.

[4]  S. Arvidson,et al.  Activation of alpha‐toxin translation in Staphylococcus aureus by the trans‐encoded antisense RNA, RNAIII. , 1995, The EMBO journal.

[5]  R. Novick,et al.  Autocrine regulation of toxin synthesis by Staphylococcus aureus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Greenberg,et al.  A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Swift,et al.  Gram-negative bacterial communication by N-acyl homoserine lactones: a universal language? , 1994, Trends in microbiology.

[8]  A. Grossman,et al.  Biochemical and genetic characterization of a competence pheromone from B. subtilis , 1994, Cell.

[9]  J. Kornblum,et al.  Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. , 1993, The EMBO journal.

[10]  M. Arthur,et al.  Genetics and mechanisms of glycopeptide resistance in enterococci , 1993, Antimicrobial Agents and Chemotherapy.

[11]  W J Martone,et al.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. , 1992, Infection control and hospital epidemiology.

[12]  J. Musser,et al.  Murine model of cutaneous infection with gram-positive cocci , 1992, Infection and immunity.

[13]  W. Noble,et al.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. , 1992, FEMS microbiology letters.

[14]  T. West,et al.  Antiserum agar method for identification of Smith type exopolysaccharides in clinical isolates of Staphylococcus aureus , 1985, Journal of clinical microbiology.